Innopsys will be attending ELRIG Drug Discovery 2025, taking place in Liverpool on October 21–22.
Groundbreaking ways to manipulate and explore biological systems are emerging at a rapid pace. These systems are becoming increasingly sophisticated, involving multiple cell types, dynamic environments, and high-dimensional readouts. With this growing complexity comes a clear demand: smart, scalable automation that can keep up with the science.
Innopsys will spotlight the latest breakthroughs in digital imaging automation. InnoQuant, our quantitative fluorescence slide scanning technology comes with no tiling, no artifacts, no post-processing. Our scanner delivers high-fidelity images of your immunostained tissue sections in record time, and enables ultra-sensitive marker quantification.
Come meet us! From concept to real-world application, we’ll be presenting a poster on “Evaluation of a novel slide scanning technology for neuroinflammation quantification in IF-stained brain sections”. We’d love to discuss your imaging challenges.
Innopsys at ELRIG 2025
📆 October 21-22nd 2025
📍Liverpool, UK
Discover more about the InnoQuant slide scanner: InnoQuant Cell and Tissue Scanner – Innopsys